GSK Expects to Distribute Over 50 Million Influenza Vaccine Doses for 2022-23 U.S. Flu Season
July 11 2022 - 3:12PM
Dow Jones News
By Kathryn Hardison
GSK PLC has begun shipping doses of its influenza vaccines to
U.S. health care providers and pharmacies ahead of the upcoming flu
season, and the company said Monday that it expects to distribute
over 50 million doses.
The distribution of GSK's quadrivalent influenza vaccine
immediately follows a licensing and lot-release approval from the
U.S. Food and Drug Administration's Center for Biologics Evaluation
and Research, GSK said.
Both FluLaval Quadrivalent and Fluarix Quadrivalent vaccines
will be available to patients six months and older, in line with
recommendations from the U.S. Centers for Disease Control and
Prevention, the company said.
GSK shares edged 0.8% higher to $17.69 Monday, up 10% for the
year.
Write to Kathryn Hardison at kathryn.hardison@wsj.com
(END) Dow Jones Newswires
July 11, 2022 15:57 ET (19:57 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
Historical Stock Chart
From Oct 2024 to Nov 2024
GSK (NYSE:GSK)
Historical Stock Chart
From Nov 2023 to Nov 2024
